Structure Therapeutics GPCR
NASDAQ GPCR
$21.19 -0.74 (-3.37%)
At close: Oct 23, 2026 · 4:00 PM EDT

Structure Therapeutics (GPCR) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Structure Therapeutics (GPCR) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Structure Therapeutics 4.53 Bn 3.18 Bn - 119.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119.09 Mn
Mar 31, 2026 151.70 Mn
Dec 31, 2025 146.17 Mn
Sep 30, 2025 195.92 Mn
Jun 30, 2025 138.00 Mn
Mar 31, 2025 150.45 Mn
Dec 31, 2024 165.50 Mn
Sep 30, 2024 66.40 Mn
Jun 30, 2024 79.50 Mn
Mar 31, 2024 33.50 Mn
Dec 31, 2023 57.00 Mn
Sep 30, 2023 45.88 Mn
Jun 30, 2023 -92.78 Mn
Mar 31, 2023 141.08 Mn
Dec 31, 2022 19.60 Mn
Sep 30, 2022 29.40 Mn
Jun 30, 2022 10.50 Mn
Mar 31, 2022 2.00 Mn
API Access

Structure Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GPCR&period=max&api_key=YOUR_API_KEY